TommyEugeneHowardMD

PubMed

• Observations Regarding the Immunogenicity of BDD-rFVIII Derived from a Mechanistic Personalized Medicine Perspective.
  Sauna, Z. E., Ameri, A., Kim, B., Yanover, C., Viel, K. R., Rajalingam, R., Cole, S. A., Howard, T. E.> ;J Thromb Haemost. 2012 Sep
• Haemophilia management: time to get personal?
  Howard, T. E.,Yanover, C.,Mahlangu, J.,Krause, A.,Viel, K. R.,Kasper, C. K.,Pratt, K. P.> ;Haemophilia. 2011 Jun 09
• Pharmacogenetics and the immunogenicity of protein therapeutics.
  Yanover, C., Jain, N., Pierce, G., Howard, T. E., Sauna, Z. E.> ;Nat Biotechnol. 2011 Oct
• Inhibitors of factor VIII in black patients with hemophilia.
  Viel, K. R., Ameri, A., Abshire, T. C., Iyer, R. V., Watts, R. G., Lutcher, C., Channell, C., Cole, S. A., Fernstrom, K. M., Nakaya, S., Kasper, C. K., Thompson, A. R....> ;N Engl J Med. 2009 Apr 16
• A nonstop mutation in the factor (F)X gene of a severely haemorrhagic patient with complete absence of coagulation FX.
  Ameri, A., Machiah, D. K., Tran, T. T., Channell, C., Crenshaw, V., Fernstrom, K., Khachidze, M., Duncan, A., Fuchs, S., Howard, T. E.> ;Thromb Haemost. 2007 Dec
• Functional analysis of the genetic variability in the F7 gene promoter.
  Sabater-Lleal, M., Chillón, M., Howard, T. E., Gil, E., Almasy, L., Blangero, J., Fontcuberta, J., Soria, J. M.> ;Atherosclerosis. 2007 Dec
• A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.
  Viel, K. R., Machiah, D. K., Warren, D. M., Khachidze, M., Buil, A., Fernstrom, K., Souto, J. C., Peralta, J. M., Smith, T., Blangero, J., Porter, S., Warren, S. T., F...> ;Blood. 2007 May 1
• A comparison of discrete versus continuous environment in a variance components-based linkage analysis of the COGA data.
  Viel, K. R., Warren, D. M., Buil, A., Dyer, T. D., Howard, T. E., Almasy, L.> ;BMC Genet. 2005
• Join now to see all